Corpus ID: 2543504

Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.

@article{Rosenthale1976ImmunopharmacologicPO,
  title={Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.},
  author={M. Rosenthale and A. J. Begany and A. Dervinis and J. Sellstedt and C. Guinosso and M. Gluckman},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1976},
  volume={197 1},
  pages={
          153-62
        }
}
  • M. Rosenthale, A. J. Begany, +3 authors M. Gluckman
  • Published 1976
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • In a series of tests designed to illustrate immune reactions similar to those obtained in atopic disease, Wy-16,922 effectively inhibited reaginic-mediated immunologic reactions in the skin, longs and mast cell. It was found to be devoid of immunosuppressant, antimediator, anti-inflammatory, steroid or bronchodilator properties as well as acute toxicity. Although the mechanism of action Wy-16,922 is unknown, it appears to limit the release (not the effects) of allergic mediators in a manner… CONTINUE READING
    12 Citations
    Oxamates derived from 5‐aminopyrazoles
    • 21